Drug Product Characterization
Characterization of Nucleic Acid Drug Products As nucleic acid therapeutics rapidly evolve; your development program may require innovative strategies tailored to these specialized products. Our experience spans various types of nucleic acid-based drug products, including high-concentration oligonucleotide formulations, lipid nanoparticles (LNP), virus-like particles (VLP), viruses, and other nanoparticle formulations. Within this dynamic landscape, gaining a […]
Drug Product Characterization Read More »